New Onset Diabetes After Transplantation (NODAT) - scientific data review

被引:3
作者
Zielinska, Katarzyna [1 ]
Kukulski, Leszek [2 ]
Wrobel, Marta [1 ]
Przybylowski, Piotr [3 ,4 ]
Zielinska, Marta [1 ]
Strojek, Krzysztof [1 ]
机构
[1] Med Univ Silesia, Fac Med Sci Zabrze, Dept Internal Dis Diabetol & Cardiometab Dis, M Curie Sklodowskiej 9, PL-41800 Katowice, Poland
[2] Med Univ Silesia, Fac Med Sci Zabrze, Dept Cardiac Vasc & Endovasc Surg & Transplantol, Katowice, Poland
[3] Silesian Ctr Heart Dis, Dept Cardiac Transplantat & Mech Circulatory Supp, Zabrze, Poland
[4] Jagiellonian Univ, Med Coll, Chair Gen Surg 1, Krakow, Poland
来源
CLINICAL DIABETOLOGY | 2020年 / 9卷 / 05期
关键词
new onset diabetes after transplantation; risk factors; diagnostics; treatment; KIDNEY-TRANSPLANTATION; RENAL-TRANSPLANTATION; CYTOMEGALOVIRUS-INFECTION; CARDIOVASCULAR OUTCOMES; INSULIN-RESISTANCE; RISK-FACTORS; MELLITUS; IMPACT; RECIPIENTS; HYPERGLYCEMIA;
D O I
10.5603/DK.2020.0047
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
New onset diabetes after transplantation (NODAT) is one of the most common and serious complications of solid organ transplantation. The incidence of NODAT is estimated to range from 2% to 53%. Patients who develop new onset diabetes after transplantation are significantly more frequently exposed to a higher risk of death and cardiovascular incidents as well as other adverse effects, such as decreased patient survival, higher infection rates and early graft loss. Identifying high-risk patients, undertaking preventive action and applying appropriate treatment can limit the development of new onset diabetes after transplantation and improve a patient's long-term prognosis.
引用
收藏
页码:356 / 366
页数:11
相关论文
共 51 条
[1]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]  
2-S
[3]  
Alebiosu Olutayo C, 2005, Afr Health Sci, V5, P255
[4]   Should an oral glucose tolerance test be performed routinely in all renal transplant recipients? [J].
Armstrong, Kirsten A. ;
Prins, Johannes B. ;
Beller, Elaine M. ;
Campbell, Scott B. ;
Hawley, Carmel M. ;
Johnson, David W. ;
Isbel, Nicole M. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (01) :100-108
[5]   Posttransplant diabetes mellitus in liver transplant recipients: Risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality [J].
Baid, S ;
Cosimi, AB ;
Farrell, ML ;
Schoenfeld, DA ;
Feng, S ;
Chung, RT ;
Tolkoff-Rubin, N ;
Pascual, M .
TRANSPLANTATION, 2001, 72 (06) :1066-1072
[6]   Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis [J].
Balas, Bogdan ;
Belfort, Renata ;
Harrison, Stephen A. ;
Darland, Celia ;
Finch, Joan ;
Schenker, Steven ;
Gastaldelli, Amalia ;
Cusi, Kenneth .
JOURNAL OF HEPATOLOGY, 2007, 47 (04) :565-570
[7]   Undiagnosed Diabetes in Kidney Transplant Candidates: A Case-Finding Strategy [J].
Bergrem, Henrik Andreas ;
Valderhaug, Tone Gretland ;
Hartmann, Anders ;
Hjelmesaeth, Joran ;
Leivestad, Torbjorn ;
Bergrem, Harald ;
Jenssen, Trond .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (04) :616-622
[8]   New-onset diabetes mellitus in the kidney recipient: Diagnosis and management strategies [J].
Bloom, Roy D. ;
Crutchlow, Michael F. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 :S38-S48
[9]   Efficacy and Safety of Sitagliptin for the Treatment of New-Onset Diabetes after Renal Transplantation [J].
Boerner, Brian P. ;
Miles, Clifford D. ;
Shivaswamy, Vijay .
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2014, 2014
[10]   Management Strategies for Posttransplant Diabetes Mellitus after Heart Transplantation: A Review [J].
Cehic, Matthew G. ;
Nundall, Nishant ;
Greenfield, Jerry R. ;
Macdonald, Peter S. .
JOURNAL OF TRANSPLANTATION, 2018, 2018